| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |